Novavax stock today: NVAX closes up 6% as Singapore rolls out JN.1 Novavax COVID shot
NEW YORK, January 3, 2026, 05:15 ET — Market closed Novavax Inc (NVAX.O) shares rose 6.1% on Friday to close at $7.13, outperforming in a mixed U.S. session as traders latched onto fresh signs of overseas demand for its updated COVID-19 shot. The stock traded about 38% below its 52-week high of $11.55 set on Jan. 7 last year, according to MarketWatch data. MarketWatch The move matters because it ties the stock to a concrete, near-term distribution window in a government-backed program. Singapore’s Communicable Diseases Agency said the JN.1 Novavax/Nuvaxovid vaccine will be offered at selected general practitioner clinics under